15:27 , May 25, 2018 |  BC Week In Review  |  Company News

Takeda divests stake in Chinese JV Techpool

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on May 23 that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a...
22:34 , May 23, 2018 |  BC Extra  |  Company News

Takeda divests stake in Chinese JV

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) spokesperson Vince Docherty told BioCentury on Wednesday that the pharma's divestment of critical care and API manufacturing JV Guangdong Techpool Bio-Pharma Co. Ltd. (Guangzhou, China) does not signal a strategic...
17:55 , May 11, 2018 |  BC Week In Review  |  Company News

Shire acquisition to give Takeda new global footprint

With an agreement to acquire Shire plc (LSE:SHP; NASDAQ:SHPG) now in hand, Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is poised to expand its U.S. presence through the creation of a combined company that makes good on...
22:18 , May 8, 2018 |  BC Extra  |  Company News

Shire deal to rebalance Takeda's global footprint

With an agreement to acquire Shire plc (LSE:SHP; NASDAQ:SHPG) now in hand, Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is poised to expand its U.S. presence through the creation of a combined company that makes good on...
19:09 , Apr 20, 2018 |  BC Week In Review  |  Company News

Shire rejects third Takeda bid, mulling fourth

Shire plc (LSE:SHP; NASDAQ:SHPG) said April 19 its board had unanimously rejected three separate takeout offers from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), culminating at the most recent bid valued at £44 billion ($62.7 billion) in...
00:03 , Apr 20, 2018 |  BC Extra  |  Company News

Shire rejects third Takeda bid, as Allergan drops out

Shire plc (LSE:SHP; NASDAQ:SHPG) said Thursday its board has unanimously rejected three separate takeout offers from Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), culminating at the most recent bid valued at £44 billion ($62.7 billion) in which...
17:45 , Mar 30, 2018 |  BC Week In Review  |  Company News

Takeda mulls Shire takeover

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it is considering a takeout of Shire plc (LSE:SHP; NASDAQ:SHPG), a move the pharma believes would strengthen its core pipeline areas of focus while adding Shire's expertise in rare...
22:09 , Mar 28, 2018 |  BC Extra  |  Company News

Shire posts big gain as Takeda mulls takeover

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said it is considering a takeout of Shire plc (LSE:SHP; NASDAQ:SHPG), a move the pharma believes would strengthen its core pipeline areas of focus while adding Shire's expertise in rare...
07:00 , May 30, 2016 |  BioCentury  |  Strategy

Taking Takeda global

Two years after joining Takeda Pharmaceutical Co. Ltd. , Christophe Weber has narrowed the company's therapeutic focus, expanded the executive team and reorganized its approach to market with the aim of transforming the company into...
08:00 , Feb 23, 2015 |  BC Week In Review  |  Clinical News

Daliresp roflumilast: Phase III/IV data

The 1-year, double-blind, international Phase III/IV REACT trial in 1,945 patients showed that 500 µg daily oral Daxas plus a long-acting beta 2 agonist (LABA) and an inhaled corticosteroid (ICS) with or without a long-acting...